-
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Average Rating of "Buy" from Analysts
Source: Buzz FX / 23 Sep 2024 04:01:10 America/Chicago
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Average Rating of "Buy" from Analysts Written by MarketBeat September 23, 2024 Share Link copied to clipboard. Shares of 4D Molecular Therapeutics, Inc.
Read more...